Back to Search
Start Over
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
- Source :
- Blood Cancer Journal, Vol 12, Iss 4, Pp 1-4 (2022)
- Publication Year :
- 2022
- Publisher :
- Nature Publishing Group, 2022.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20445385
- Volume :
- 12
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Blood Cancer Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.9439160d2b6347a49069ee0eef6d91a9
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41408-022-00667-9